Michael Ferguson is an Independent Director of NanoVibronix, Inc. In January 2009, Mr. Ferguson founded Ferguson Strategies, LLC, a government affairs and strategic business consulting firm, where he serves as the chief executive officer and chairman. From 2001 to January 2009, he served in the U.S. House of Representatives, representing New Jersey’s 7th congressional district. While in Congress, he was a member of the House Energy and Commerce Committee, which has wide jurisdiction over the healthcare, telecommunications and energy industries. He served as vice chairman of the panel’s Health Subcommittee, where he became a key member on health care issues and helped to ensure passage of the Medicare Part D prescription drug benefit in 2003. In addition, he served as a member of the Telecommunications and Internet Subcommittee as well as the Oversight and Investigations Subcommittee. Mr. Ferguson was also a member of the House Financial Services Committee, where he cosponsored the Sarbanes-Oxley Act of 2002 and helped enact the initial terrorism risk insurance law. Congressman Ferguson currently serves as a senior fellow of the Center for Medicine in the Public Interest’s Odyssey Initiative for Biomedical Innovation and Human Health. He has also served on various corporate advisory boards and committees, including for Pfizer, Inc., the National Italian American Foundation and the United States Golf Association. Mr. Ferguson received a bachelor’s degree in government from the University of Notre Dame and a master’s of public policy degree with a specialization in education policy from Georgetown University.
Michael Ferguson is 43, he's been the Independent Director of NanoVibronix Inc since 2015. There are 9 older and no younger executives at NanoVibronix Inc. The oldest executive at NanoVibronix Inc is William Stern, 72, who is the President.
Michael's mailing address filed with the SEC is C/O NANOVIBRONIX, INC., 525 EXECUTIVE BOULEVARD, ELMSFORD, NY, 10523.
Over the last 8 years, insiders at NanoVibronix Inc have traded over $0 worth of NanoVibronix Inc stock and bought 131,000 units worth $98,060 . The most active insiders traders include Christopher M Fashek, Thomas Mika und Harold Jacob. On average, NanoVibronix Inc executives and independent directors trade stock every 190 days with the average trade being worth of $14,078. The most recent stock trade was executed by Thomas Mika on 5 January 2023, trading 50,000 units of NAOV stock currently worth $12,500.
nanovibronix inc. is a medical device company that is focused on creating medical products utilizing its proprietary low intensity acoustic technology. the company's patented technology allows for creation of miniature transducers that transmit low-frequency, low-intensity ultrasound through flexible material surfaces. this unique development may be utilized for a variety of medical requiring low cost therapeutic ultrasound applications. the company's patch based product diagnosis, painshield®, carries an fda clearance. nanovibronix catheter based products include the cathbottm . nanovibronix inc. is located in elmsford, ny. its subsidiary, nanovibronix ltd. is located in nesher, israel.
NanoVibronix Inc executives and other stock owners filed with the SEC include: